Screening costs associated with donor selection for fecal microbiota transplantation for treatment of PD-1 refractory melanoma patients

The gut microbiome acts as a tumor-extrinsic regulator of responses to immune-checkpoint inhibitors (ICIs) targeting PD-1 and CTLA-4 receptors. Primary resistance to anti-PD-1 ICI can be reversed via responder-derived fecal microbiota transplant (FMT) in patients with refractory melanoma. Efforts to...

Descripción completa

Detalles Bibliográficos
Autores principales: Fortman, Dylan, Avellan, Maria G. Pazan, Hurd, Drew, Schwartz, Marc, Dubner, Howard, Hewitt, Corey, Berton, Samantha, Ernst, Scarlett, Rose, Amy, Zarour, Hong Wangd, Hassane, Davar, Diwakar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Articles: Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949524/
https://www.ncbi.nlm.nih.gov/pubmed/36806616
http://dx.doi.org/10.1097/CMR.0000000000000871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949524/
https://www.ncbi.nlm.nih.gov/pubmed/36806616
http://dx.doi.org/10.1097/CMR.0000000000000871

Ejemplares similares